No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs371558245 |
chr1:85461862-85461863 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs545366097 |
chr1:85461914-85461915 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs369955419 |
chr1:85461933-85461934 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs10873677 |
chr1:85461946-85461947 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
5 |
rs187514871 |
chr1:85461953-85461954 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs111708666 |
chr1:85461975-85461976 |
Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs201537499 |
chr1:85462077-85462078 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs200659040 |
chr1:85462089-85462090 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs201403803 |
chr1:85462101-85462102 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs199778552 |
chr1:85462102-85462103 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs75518024 |
chr1:85462105-85462106 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs57506831 |
chr1:85462114-85462115 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs145260540 |
chr1:85462132-85462133 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs538363702 |
chr1:85462137-85462138 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs192033573 |
chr1:85462173-85462174 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs4907119 |
chr1:85462194-85462195 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
mRNA abundance
|
17 |
rs543820546 |
chr1:85462236-85462237 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs114977652 |
chr1:85462246-85462247 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs145392536 |
chr1:85462262-85462263 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs199880726 |
chr1:85462494-85462495 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs77452813 |
chr1:85462498-85462499 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs202107934 |
chr1:85462507-85462508 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs138052421 |
chr1:85462511-85462512 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs545503592 |
chr1:85462528-85462529 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs149504313 |
chr1:85462557-85462558 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs11161503 |
chr1:85462582-85462583 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
27 |
rs550689767 |
chr1:85462609-85462610 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs567663887 |
chr1:85462612-85462613 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs530316101 |
chr1:85462618-85462619 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs546856011 |
chr1:85462627-85462628 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs149226662 |
chr1:85462644-85462645 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs11161504 |
chr1:85462652-85462653 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'
|
TF binding region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
33 |
rs11161505 |
chr1:85462665-85462666 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'
|
TF binding region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
34 |
rs532664263 |
chr1:85462674-85462675 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs568853211 |
chr1:85462684-85462685 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs11804811 |
chr1:85462692-85462693 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs554247093 |
chr1:85462722-85462723 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs574818216 |
chr1:85462729-85462730 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs540546215 |
chr1:85462748-85462749 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs920340 |
chr1:85462750-85462751 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'
|
TF binding regionCpG island
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
41 |
rs114037164 |
chr1:85462772-85462773 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs545639110 |
chr1:85462777-85462778 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs112297575 |
chr1:85462799-85462800 |
Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs371534810 |
chr1:85462802-85462803 |
Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Flanking Bivalent TSS/Enh
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs369012332 |
chr1:85462812-85462813 |
Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Flanking Bivalent TSS/Enh
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs530905003 |
chr1:85462822-85462823 |
Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Flanking Bivalent TSS/Enh
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs554605802 |
chr1:85462852-85462853 |
Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Flanking Bivalent TSS/Enh
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs72066647 |
chr1:85462853-85462854 |
Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Flanking Bivalent TSS/Enh
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs544621524 |
chr1:85462862-85462863 |
Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Flanking Bivalent TSS/Enh
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs57248654 |
chr1:85462875-85462876 |
Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Flanking Bivalent TSS/Enh
|
TF binding regionCpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|